http://www.pharmalot.com/2008/09/imclone-to-pursue-a-deal-with-its-mystery-suitor/ News, Comment and Conversation Fri, 10 Feb 2012 21:07:51 +0000 http://wordpress.org/?v=2.6.2 http://www.pharmalot.com/2008/09/imclone-to-pursue-a-deal-with-its-mystery-suitor/#comment-377122 Scott Thu, 02 Oct 2008 13:23:51 +0000 http://www.pharmalot.com/?p=16028#comment-377122 If Lilly did make an offer for $70/share, Bristol Myers Squibb should let them have it and thank Lilly for it! Imclone isn't worth that price. Regardless, however, Icahn also has a significant stake in Amylin, and it would seem to me that a LLY acquisition of that company seems far more likely (and beneficial). But LLY doesn't have that much cash, so it may be just a show to prevent anyone from trying to buy Lill! If Lilly did make an offer for $70/share, Bristol Myers Squibb should let them have it and thank Lilly for it! Imclone isn’t worth that price. Regardless, however, Icahn also has a significant stake in Amylin, and it would seem to me that a LLY acquisition of that company seems far more likely (and beneficial). But LLY doesn’t have that much cash, so it may be just a show to prevent anyone from trying to buy Lill!

]]>